UNICREDIT BANK/PUT/FERRARI N.V./290/0.1/20.06.24 Share Price

Warrant

UC92QH

DE000HC92QH4

Market Closed - Borsa Italiana 21:40:51 18/06/2024 BST
0.0025 EUR 0.00% Intraday chart for UNICREDIT BANK/PUT/FERRARI N.V./290/0.1/20.06.24
Current month-90.71%
1 month-94.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
18/06/24 0.0025 0.00%
17/06/24 0.0013 -80.00%
14/06/24 0.0065 +8.33%
13/06/24 0.006 0.00%
12/06/24 0.006 0.00%

Real-time Borsa Italiana

Last update June 18, 2024 at 09:40 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying FERRARI N.V.
IssuerLogo Issuer UniCredit UniCredit
UC92QH
ISINDE000HC92QH4
Date issued 05/09/2023
Strike 290
Maturity 20/06/2024 (2 Days)
Parity 10 : 1
Emission price-
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.16
Lowest since issue 0.0013

Company Profile

Ferrari N.V. is a holding company organized around 3 areas of activity: - manufacturing and sale of luxury sports vehicles (85.8% of net sales): 458 Italia, 488 GTB, 458 Spider, 488 Spider, F12 Berlinetta, 458 Speciale, 458 Speciale A, California T and Ferrari FF. The group also provides spare parts; - manufacturing and sale of car engines (2.1%): Maseratti brand; - other (12.1%): sponsorship activity, provision of financial services, etc. Net sales are distributed geographically as follows: Italy (7.4%), the United Kingdom (10.5%), Germany (8.3%), Europe/Middle East/Africa (21.9%), the United States (25.7%), Americas (3.8%), China/Hong Kong/Taiwan (9.8%), Asia/Pacific and Australia (12.6%).
Sector
-
More about the company

Ratings for Ferrari N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Ferrari N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
388 EUR
Average target price
398.9 EUR
Spread / Average Target
+2.80%
Consensus
  1. Stock Market
  2. Warrants
  3. UC92QH Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW